Trials / Conditions / Recurrent Vulvar Carcinoma

Recurrent Vulvar Carcinoma

5 registered clinical trials studyying Recurrent Vulvar Carcinoma.

Status	Trial	Sponsor	Phase
Suspended	Paclitaxel Therapeutic Drug Monitoring in Cancer Patients NCT03987555	Wake Forest University Health Sciences	—
Terminated	DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating P NCT03439085	M.D. Anderson Cancer Center	Phase 2
Completed	Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Me NCT03452332	M.D. Anderson Cancer Center	Phase 1
Completed	Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malig NCT02578888	Albert Einstein College of Medicine	N/A
Completed	Collecting Tumor Samples From Patients With Gynecological Tumors NCT00897442	Gynecologic Oncology Group	—